![David C. Bunton](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David C. Bunton
Fondatore presso Biopta Ltd.
Posizioni attive di David C. Bunton
Società | Posizione | Inizio | Fine |
---|---|---|---|
Biopta Ltd.
![]() Biopta Ltd. Miscellaneous Commercial ServicesCommercial Services Biopta Ltd. provides biological research and human tissues in drug development. It conducts research on the effect of drug activity prior to clinical trials using fresh human tissues. The firm engages in the use of functional human tissue to predict drug activity prior to clinical trials. It provides lab services, comparative pharmacology, clinical biopsies, in vitro and ex vivo techniques, and customized services, as well as cardiac, vascular, respiratory, gastrointestinal, human absorption, skin, and genitourinary related services. The company was founded by David Bunton and Chris Hillier and in 2002 and is headquartered in Glasgow, the United Kingdom. | Direttore/Membro del Consiglio | 01/01/2002 | - |
Amministratore Delegato | 07/12/2009 | - | |
Fondatore | 01/01/2002 | - | |
Direttore operativo | 01/01/2002 | 07/12/2009 | |
British Pharmacological Society
![]() British Pharmacological Society Investment Trusts/Mutual FundsMiscellaneous The British Pharmacological Society is a charity and membership organization that aims to promote and advance the field of pharmacology. The private company is based in London, UK. The British company leads the way in researching and applying pharmacology worldwide. The company was founded in 1931. Rachel Lambert-Forsyth has been the CEO of the company since 2020. | Corporate Officer/Principal | - | - |
Safety Pharmacology Society | Corporate Officer/Principal | - | - |
ReproCELL Europe Ltd.
![]() ReproCELL Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Part of ReproCELL, Inc., ReproCELL Europe Ltd. is a British company that specializes in providing solutions for translating scientific discoveries into therapies. The company is based in Glasgow, UK. The company's expertise lies in human tissue and stem cells, and they offer consultation services to researchers facing challenges in their research. David C. Bunton has been the CEO of the company since 2017. | Amministratore Delegato | 11/08/2017 | - |
Storia della carriera di David C. Bunton
Formazione di David C. Bunton
University of Glasgow | Undergraduate Degree |
Glasgow Caledonian University | Doctorate Degree |
Statistiche
Distribuzione geografica
Regno Unito | 6 |
Stati Uniti | 2 |
Posizioni
Corporate Officer/Principal | 2 |
Chief Executive Officer | 2 |
Director/Board Member | 1 |
Settori
Commercial Services | 3 |
Consumer Services | 3 |
Miscellaneous | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 4 |
---|---|
Biopta Ltd.
![]() Biopta Ltd. Miscellaneous Commercial ServicesCommercial Services Biopta Ltd. provides biological research and human tissues in drug development. It conducts research on the effect of drug activity prior to clinical trials using fresh human tissues. The firm engages in the use of functional human tissue to predict drug activity prior to clinical trials. It provides lab services, comparative pharmacology, clinical biopsies, in vitro and ex vivo techniques, and customized services, as well as cardiac, vascular, respiratory, gastrointestinal, human absorption, skin, and genitourinary related services. The company was founded by David Bunton and Chris Hillier and in 2002 and is headquartered in Glasgow, the United Kingdom. | Commercial Services |
British Pharmacological Society
![]() British Pharmacological Society Investment Trusts/Mutual FundsMiscellaneous The British Pharmacological Society is a charity and membership organization that aims to promote and advance the field of pharmacology. The private company is based in London, UK. The British company leads the way in researching and applying pharmacology worldwide. The company was founded in 1931. Rachel Lambert-Forsyth has been the CEO of the company since 2020. | Miscellaneous |
Safety Pharmacology Society | |
ReproCELL Europe Ltd.
![]() ReproCELL Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Part of ReproCELL, Inc., ReproCELL Europe Ltd. is a British company that specializes in providing solutions for translating scientific discoveries into therapies. The company is based in Glasgow, UK. The company's expertise lies in human tissue and stem cells, and they offer consultation services to researchers facing challenges in their research. David C. Bunton has been the CEO of the company since 2017. | Commercial Services |
- Borsa valori
- Insiders
- David C. Bunton
- Esperienza